Sign In
Buy NUS
$5.27
+0.0400 (+0.765%)
At Close: Jul 13, 2026
July Graham Value All-Stars (GVAS) Emit 10 Beaming Buys
06:01am, Saturday, 11'th Jul 2026
July's GVAS Dogs list highlights ten fair-priced, high-yield large-cap stocks, including IRSA Inversiones, Weibo, Verizon, and AT&T, as ideal buys. Analyst targets project average net gains of 40.39%
20 July Ideal 'Safer' Russell Index Buys You Might Choose To Hold Forever
02:42pm, Thursday, 09'th Jul 2026
Russell 2000 & 3000 Maybe Hold Forever Stocks (MHFS) featured high (>4%) dividends, attractive or neutral ratings, >2-year dividend history, and positive cash flow per YCharts stock screener. The resu
5 Undervalued Stocks With Attractive Price-to-Sales Ratios
09:55am, Tuesday, 30'th Jun 2026
5 low price-to-sales stocks passed a value screen that combines valuation, debt and quality metrics to highlight potential upside opportunities.
Nu Skin Enterprises: Working Capital Intensity, A Lot Riding On India
09:55am, Tuesday, 30'th Jun 2026
Nu Skin Enterprises (NUS) faces low profitability and macro-driven sales headwinds, with limited recession resistance and weak operating cash flow. The India market expansion is a key strategic focus,
5 Beauty & Cosmetics Stocks to Buy for a Stable Portfolio in 2H 2026
09:40am, Tuesday, 30'th Jun 2026
EL, HELE, NUS, KVUE and IPAR stand out as beauty and cosmetics stocks backed by growth strategies for 2H 2026.
Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
11:16am, Monday, 29'th Jun 2026
Nu Skin (NUS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
4 Cosmetics Stocks Worth Watching on Favorable Industry Trends
12:01pm, Wednesday, 17'th Jun 2026
EL, ELF, HELE and NUS are benefiting from growing skincare demand, product innovation and expanding digital channels.
5 Value Stocks With Low Price-to-Sales Ratios & Massive Upside
10:51am, Tuesday, 16'th Jun 2026
CAL, GIII, NUS, APLE and EVER screen as low price-to-sales value stocks with upside potential, backed by valuation and debt filters.
13 Lucky Dogs: June Graham Value All-Stars (GVAS)
07:49am, Thursday, 04'th Jun 2026
The June GVAS portfolio highlights 13 'safer,' fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins. Top ten GVAS stocks are forecasted to deliver average
5 Bargain Low Price-to-Sales Stocks Positioned to Deliver Solid Gains
10:01am, Tuesday, 02'nd Jun 2026
Price-to-sales screens can uncover discounted growth when earnings are thin, pairing low P/S with balance-sheet and value checks for upside.
5 Value Stocks Trading at Attractive Price-to-Sales Ratios
10:46am, Thursday, 21'st May 2026
Low price-to-sales stocks like SCVL, NUS, APLE, COP and FAF screen as undervalued, with the setup hinging on debt levels, strong cash flow and business momentum.
3 Cosmetics Stocks Gaining From AI, Wellness and Innovation Trends
09:56am, Wednesday, 20'th May 2026
EL, NUS and COTY tap AI, wellness and innovation trends as beauty demand evolves across skincare, cosmetics and fragrance categories.
Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition
07:00am, Friday, 15'th May 2026
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS), a global leader in beauty and wellness, today announced it has reached the milestone of providing 900 million meals for children si
Nu Skin Enterprises Q1 Earnings Call Highlights
04:09am, Wednesday, 13'th May 2026
Nu Skin Enterprises NYSE: NUS reported first-quarter 2026 results that management said were in line with expectations, as the company continued to invest in its Prysm iO wellness platform and emerging
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26
01:34pm, Friday, 08'th May 2026
Dallas, Texas--(Newsfile Corp. - May 8, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, a
